XML 48 R34.htm IDEA: XBRL DOCUMENT v3.25.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets (Liabilities)

Significant components of the Company’s deferred tax assets (liabilities) are as follows:

 

 

 

As of December 31,

 

 

 

2024

 

 

2023

 

Gross deferred tax assets (liabilities):

 

 

 

 

 

 

Net operating loss carryforwards

 

$

52,441

 

 

$

45,197

 

Tax credit carryforwards

 

 

4,173

 

 

 

3,975

 

Fixed assets

 

 

(130

)

 

 

(138

)

Stock-based compensation

 

 

3,044

 

 

 

2,398

 

Capitalized R&D

 

 

11,780

 

 

 

8,594

 

Deferred revenue

 

 

612

 

 

 

669

 

Other

 

 

256

 

 

 

122

 

Total deferred tax assets

 

 

72,176

 

 

 

60,817

 

Valuation allowance

 

 

(72,176

)

 

 

(60,817

)

Net deferred tax assets (liabilities)

 

$

 

 

$

 

Schedule of Reconciliation of Anticipated Income Tax Expense Benefit Computed by Statutory Federal Income Tax Rate A reconciliation of the income tax expense at the federal statutory tax rate to the Company’s effective income tax rate follows:

 

 

 

As of December 31,

 

 

 

2024

 

 

2023

 

Statutory tax rate

 

 

21.0

%

 

 

21.0

%

State taxes, net of federal benefit

 

 

5.7

%

 

 

1.9

%

Federal research and development credit

 

 

%

 

 

(3.9

)%

Stock-based compensation

 

 

(1.2

)%

 

 

(1.8

)%

Deferred tax adjustment resulting from tax rate change

 

 

2.6

%

 

 

(0.2

)%

Other

 

 

(0.2

)%

 

 

(0.2

)%

Valuation allowance

 

 

(27.9

)%

 

 

(16.8

)%

Effective tax rate

 

 

0.0

%

 

 

0.0

%

Schedule of Tax Net Operating Loss Carryforward and Tax Credit Carryforward

As of December 31, 2024, the Company had the following tax net operating loss carryforwards available to reduce future federal and state taxable income, and tax credit carryforwards available to offset future federal and state income taxes:

 

 

 

Hyperfine

 

 

Amount

 

 

Begin to Expire in

Hyperfine tax net operating loss carryforwards:

 

 

 

 

 

Federal (pre-2018 NOLs)

 

$

12,084

 

 

2034

Federal (post-2017 NOLs)

 

 

183,030

 

 

No Expiration

States

 

 

124,274

 

 

2031

Tax credit carryforwards:

 

 

 

 

 

Federal research and development

 

 

2,440

 

 

2034

Connecticut research and development

 

 

1,538

 

 

No Expiration

Connecticut others

 

 

6

 

 

2025

Federal others

 

 

2

 

 

2025

 

 

 

Liminal

 

 

Amount

 

 

Begin to Expire in

Liminal tax net operating loss carryforwards:

 

 

 

 

 

Federal (pre-2018 NOLs)

 

$

 

 

 

Federal (post-2017 NOLs)

 

 

15,625

 

 

No Expiration

States

 

 

15,621

 

 

2038

Tax credit carryforwards:

 

 

 

 

 

Federal research and development

 

 

448

 

 

2038

Connecticut research and development

 

 

81

 

 

No Expiration

Federal and state other

 

 

2

 

 

2025